Picture of Hofseth Biocare ASA logo

HBC Hofseth Biocare ASA News Story

0.000.00%
no flag iconLast trade - 00:00
Consumer DefensivesSpeculativeMicro CapSucker Stock

Brief: Hofseth Biocare: new study shows ProGo significantly reduces BMI

Feb 9 (Reuters) - Hofseth Biocare ASA  HOFBC.OL : 
    * Says new study shows ProGo significantly reduces BMI 
    * Study shows that a daily dietary intake of 16 g of HBCs salmon protein hydrolysate powder 
for 42 days, statistically significantly reduced Body Mass Index by 5.6 pct in overweight 
subjects, in comparison with whey protein isolate as a placebo-control 
    * Says the company's new study on the effects of HBCs salmon protein ProGo has been accepted 
for publication in the Journal of Obesity & Weight Loss Therapy in USA 
 
     
Source text for Eikon:  ID:nHUG9pWpdR  
     
Further company coverage:  HOFBC.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))

Recent news on Hofseth Biocare ASA

See all news